Cargando…

Identification and validation of a genomic mutation signature as a predictor for immunotherapy in NSCLC

Currently, the benefits of immune checkpoint inhibitor (ICI) therapy prediction via emerging biomarkers have been identified, and the association between genomic mutation signatures (GMS) and immunotherapy benefits has been widely recognized as well. However, the evidence about non-small cell lung c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zemin, Ge, You, Li, Han, Fei, Gaoqiang, Wang, Shuai, Wei, Pingmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2022
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702799/ https://www.ncbi.nlm.nih.gov/pubmed/36305643 http://dx.doi.org/10.1042/BSR20220892

Ejemplares similares

Development and validation of a combined ferroptosis and immune prognostic signature for lung adenocarcinoma
por: Li, Han, et al.
Publicado: (2022)

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
por: Zhang, Yichi, et al.
Publicado: (2022)

Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma
por: Ju, Lincheng, et al.
Publicado: (2022)

The association of sex-biased ATRX mutation in female gastric cancer patients with enhanced immunotherapy-related anticancer immunity
por: Ge, You, et al.
Publicado: (2021)

Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma
por: Tu, Guangxu, et al.
Publicado: (2021)

Serum vitamin D levels and Sjogren’s syndrome: bi-directional Mendelian randomization analysis
por: Zhao, Meng, et al.
Publicado: (2023)

Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma
por: Xiao, Kai, et al.
Publicado: (2020)

Identification and validation of prognostic signature for breast cancer based on genes potentially involved in autophagy
por: Zhong, Shanliang, et al.
Publicado: (2020)

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2021)

Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma
por: Shi, Yucang, et al.
Publicado: (2022)

Epidemiological trends and incidence prediction of lung cancer in China based on the Global Burden of Disease study 2019
por: Li, Han, et al.
Publicado: (2022)

Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation
por: Zhao, Wenjing, et al.
Publicado: (2023)

Multiple genome pattern analysis and signature gene identification for the Caucasian lung adenocarcinoma patients with different tobacco exposure patterns
por: Dong, Yan-mei, et al.
Publicado: (2020)

Identification and validation of RNA‐binding protein‐related gene signature revealed potential associations with immunosuppression and drug sensitivity in glioma
por: Chen, Zhuohui, et al.
Publicado: (2021)

Autophagy-related genes prognosis signature as potential predictive markers for immunotherapy in hepatocellular carcinoma
por: Mao, Deli, et al.
Publicado: (2020)

Alteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing
por: Chen, Xiaowei, et al.
Publicado: (2020)

Development of a circHIPK3-based ceRNA network and identification of mRNA signature in breast cancer patients harboring BRCA mutation
por: Lian, Qi-xin, et al.
Publicado: (2023)

Exploration and validation of a novel prognostic signature based on comprehensive bioinformatics analysis in hepatocellular carcinoma
por: Wang, Xiaofei, et al.
Publicado: (2020)

Immune activity score to assess the prognosis, immunotherapy and chemotherapy response in gastric cancer and experimental validation
por: Wu, Xuan, et al.
Publicado: (2023)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Identification of a five-gene signature in association with overall survival for hepatocellular carcinoma
por: Yang, Lei, et al.
Publicado: (2021)

Identification of Vitamin D-related gene signature to predict colorectal cancer prognosis
por: Bu, Luping, et al.
Publicado: (2021)

Identification of a prognostic immune‐related signature for small cell lung cancer
por: Xie, Qi, et al.
Publicado: (2021)

Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma
por: Liang, Jiaying, et al.
Publicado: (2021)

Novel pyroptosis-associated genes signature for predicting the prognosis of sarcoma and validation
por: Wen, Hao, et al.
Publicado: (2022)

Construction and validation of a novel IGFBP3-related signature to predict prognosis and therapeutic decision making for Hepatocellular Carcinoma
por: Chen, Jianlin, et al.
Publicado: (2023)

Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma
por: Yue, Cheng, et al.
Publicado: (2019)

Identification of an immune prognostic 11-gene signature for lung adenocarcinoma
por: Yang, Tao, et al.
Publicado: (2021)

Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy
por: Li, Kuangxun, et al.
Publicado: (2021)

HiLDA: a statistical approach to investigate differences in mutational signatures
por: Yang, Zhi, et al.
Publicado: (2019)

The identification of gene signature and critical pathway associated with childhood-onset type 2 diabetes
por: Jia, Keren, et al.
Publicado: (2019)

Identification of a ferroptosis-related gene signature (FRGS) for predicting clinical outcome in lung adenocarcinoma
por: Wang, Sheng, et al.
Publicado: (2021)

Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis
por: Xu, Dafeng, et al.
Publicado: (2020)

Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma
por: Wang, Sheng, et al.
Publicado: (2023)

Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma
por: Li, Wanzhen, et al.
Publicado: (2021)

Identification of robust diagnostic and prognostic gene signatures in different grades of gliomas: a retrospective study
por: Liu, Jieting, et al.
Publicado: (2021)

Genome‐wide identification of CpG island methylator phenotype related gene signature as a novel prognostic biomarker of gastric cancer
por: Zeng, Zhuo, et al.
Publicado: (2020)

Development and internal validation of a nine-lncRNA prognostic signature for prediction of overall survival in colorectal cancer patients
por: Zhang, Zhiqiao, et al.
Publicado: (2018)

Identification of potential gene signatures associated with osteosarcoma by integrated bioinformatics analysis
por: Jia, Yutao, et al.
Publicado: (2021)

Bioinformatics analysis identifies COL1A1, THBS2 and SPP1 as potential predictors of patient prognosis and immunotherapy response in gastric cancer
por: Wang, Yali, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n25c2ior08rmdchv45moqrdfgl